Valitor

February is Age-Related Macular Degeneration (AMD) & Low Vision Awareness Month. AMD is a leading cause of vision loss for people over 50, potentially leading to blindness if left untreated. ? This month, we’re highlighting the importance of early detection, prevention, and treatment in preserving sight. ? At Valitor, we’re committed to advancing our multi-valent polymer (MVP) technology platform to address vision-threatening diseases, including Wet AMD, and help patients maintain their independence and quality of life. ? #AMDAwareness #LowVisionAwareness #EyeHealth #BiotechInnovation #VisionCare

This International Day of Women and Girls in Science, we celebrate the brilliant women driving innovation in biotech and beyond. At Valitor, we’re proud our team includes exceptional women scientists doing great science to improve the lives of patients. ? Advocating for women and girls in STEM isn’t just about representation—it’s about unlocking the full potential of science to transform lives. Let’s continue breaking barriers, fostering inclusion, and inspiring the next generation of women in science! ? #WomenInScience #GirlsInSTEM #STEMEquality

In honor of #NationalSTEMDay, we celebrate the power of STEM education to inspire future innovators. From groundbreaking research to advancing treatments in ophthalmology and beyond, STEM fuels our mission to treat vision-threatening diseases. Let’s keep empowering the next generation to change lives! ? #STEMEducation #FutureInnovators

1 in 3 people over the age of 65 will experience some form of vision loss due to age-related conditions like cataracts, glaucoma, and macular degeneration. ? At Valitor, we’re advancing our multi-valent polymer (MVP) technology platform to tackle vision-threatening diseases. While we innovate in the lab, there are also many preventative steps and resources available to help reduce the risk of vision loss. ? Prioritize your eye health here: https://bit.ly/3ZNlAgC ? #VisionAwarenessMonth

So grateful to work with a wonderful group of scientists :)

At Valitor, we're committed to innovation and inclusion in every step of our journey. On Women's Equality Day, we celebrate the numerous, remarkable contributions of women, including those of our colleagues who are driving breakthroughs in healthcare and ophthalmology. ? Together, we’re paving the way for a future where equality in healthcare and the workplace is not just a vision, but a reality. ? #WomensEqualityDay #VisionaryWomen

President and Chief Scientific Officer, Wesley Jackson, Ph.D., will discuss Valitor’s cutting-edge approach to ophthalmology in a presentation and panel discussion at the H.C. Wainwright & Co., LLC 4th Annual Ophthalmology Virtual Conference?on Thursday, August 15, 2024. Listen to the live or archived presentation here: https://bit.ly/4dJnDpF The panel discussion will be available on-demand for conference attendees.

My colleagues are at ARVO this week! Check out their poster or find them for more conversation about our MVP therapies.

Looking forward to another productive #arvo2024 Hope to see you there!

We are pleased to share that we are participating at the 2024 ARVO Annual Meeting taking place May 5-6, 2024 in Seattle, WA. We will present data demonstrating the preclinical performance of our MVP drug development platform, and our progress towards the development of an improved, long-acting treatment for wet age-related macular degeneration (AMD). ? At Valitor, we’re developing?improved therapies for vision threatening diseases that will be more patient-friendly by dramatically reducing the treatment frequency, while also being designed for improved long-term efficacy and reducing clinical costs required for treatment. #ARVO2024